Effectiveness of Regular Reporting of Spirometric Results on Smoking Quit Rate. (ESPIROTAB)
|ClinicalTrials.gov Identifier: NCT01296295|
Recruitment Status : Unknown
Verified February 2011 by Jordi Gol i Gurina Foundation.
Recruitment status was: Active, not recruiting
First Posted : February 15, 2011
Last Update Posted : February 15, 2011
The purpose of this study is to evaluate the effectiveness of regular reporting of spirometric results combined with smoking cessation advice on smoking quit rate in adult smokers in primary care.
Hypothesis: In adult smokers, regular reporting of spirometric test results in addition with smoking cessation advice will increase smoking quit rate.
Expected outcome: increase of smoking cessation rate .
|Condition or disease||Intervention/treatment|
|Smoking Cessation COPD||Behavioral: Lifestyle counseling and spirometry Behavioral: Smoking cessation advice|
Design: Intervention study with two randomized arms in 5 primary care centers of two health areas.
Study population: 466 smokers over the age of 18 consulting their primary care physician for any reason and who do not fulfil the exclusion criteria.
Measurements and interventions: The study data will be collected using a structured questionnaire and data collection sheets specifically designed for the study The structured questionnaire will include the following data: sociodemographics, clinical history, smoking habit, respiratory symptomatology, smoking dependence test and smoking cessation motivation test.
The data collection sheets will include information related to the spirometric results, peak expiratory flow rate and the carbon monoxide test when performed.
On visit 0, the primary care physician will give a brief structured smoking cessation advice to all patients combined with a detailed and structured discussion of the spirometric results. After this visit the patients will be randomised in two arms (control and intervention groups).
Randomisation will be performed using a computer programme.
Randomisation will be carried out by the Coordinating Centre.
Both groups will be followed up by telephone at three (visit 1) and six months (visit 2) and at one-year (visit 3) and two-year(visit 4).
During the follow up visits brief structured smoking cessation advice will be reinforced in the control group but the spirometric results will not be discussed. In the intervention group brief structured smoking cessation advice will be reinforced with a detailed structured reminder discussion of the results obtained from the spyrometry of visit 0.
Follow up visits 1 and 2 will be undertaken by telephone and the patients will be asked about their smoking habit and will be given a brief questionnaire.
One month before visits 3 and 4 both groups will undergo the same series of tests performed prior to visit 0 with the exception of the peak expiratory flow rate. Spirometry will be done only in the intervention group.
On visits 3 and 4, the same intervention will be done. On both visits 3 and 4 all the participants who report smoking withdrawal will undergo the carbon monoxide test.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||466 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Effectiveness of Regular Reporting of Spirometric Results Combined With a Smoking Cessation Advice by a Primary Care Physician on Smoking Quit Rate in Adult Smokers: a Randomized Controlled Trial.|
|Study Start Date :||January 2005|
|Primary Completion Date :||December 2010|
|Estimated Study Completion Date :||March 2011|
Experimental: Spirometry and lifestyle counseling
Intervention group: The intervention is to give brief structured smoking cessation advice combined with a detailed and structured discussion of the spirometric results.
Behavioral: Lifestyle counseling and spirometry
The patients of the intervention group will be given a brief structured smoking cessation advice by their primary care physician combined with a detailed and structured discussion of the spirometry results.
No Intervention: Lifestyle counseling
No intervention group: the patients of the control group will receive a brief structured smoking cessation advice.
Behavioral: Smoking cessation advice
Brief smoking cessation advice
- Smoking abstinence: self reported abstinence (12 or more months smoking free. [ Time Frame: 24 months after last recruitment ]Smoking cessation confirmed by air carbon monoxide concentration. Safety Issue?: (FDAAA) No
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01296295
|Jordi Gol i Gurina Foundation|
|Principal Investigator:||Mar Rodriguez||Institut Catalá de la Salut|